New emollient with topical corticosteroid-sparing effect in treatment of childhood atopic dermatitis: SCORAD and quality of life improvement

Pediatric Dermatology

Volumn 25, Issue 6, 2008, Pages 606-612

  Msika, Philippe ^a   De Belilovsky, Clarence ^b   Piccardi, Nathalie ^a   Chebassier, Nathalie ^c   Baudouin, Caroline ^a   Chadoutaud, Bernard ^d  

^a Laboratoires Expanscience   (France)

^b INSTITUT ALFRED FOURNIER   (France)

^c Ad'Missions ^*  (France)

^d ClinReal Online   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DESONIDE; EMOLLIENT AGENT; STELATOPIA; UNCLASSIFIED DRUG;

ARTICLE; ATOPIC DERMATITIS; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; INFANT; LICHENOID ERUPTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARENT; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EMOLLIENTS; FEMALE; HUMANS; INFANT; MALE; PARENTS; PLANT OILS; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 57049109197     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2008.00783.x     Document Type: Article

References (23)

1. Simpson EL, Hanifin JM. Atopic dermatitis. J Am Acad Dermatol 2005 53 : 115 128.
2. Warschburger P, Buchholz HT, Petermann F. Psychological adjustment in parents of young children with atopic dermatitis: which factors predict parental quality of life? Br J Dermatol 2004 150 : 304 311.
3. Berth-Jones J, Finlay AY, Zaki I et al. Cyclosporine in severe childhood atopic dermatitis: a multicenter study. J Am Acad Dermatol 1996 34 : 1016 1021.
4. Lawson V, Lewis-Jones MS, Finlay AY et al. The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire. Br J Dermatol 1998 138 : 107 113.
5. Lewis-Jones MS, Finlay AY, Dykes PJ. The Infants' Dermatitis Quality of Life Index. Br J Dermatol 2001 144 : 104 110.
6. Proksch E, Jensen JM, Elias PM. Skin lipids and epidermal differentiation in atopic dermatitis. Clin Dermatol 2003 21 : 134 144.
7. Piccirilli A, Choulot JC, Piccardi N et al. Sunflower oil oleodistillate for atopy treatment: an in vitro and clinical evaluation. J Eur Acad Dermatol Venereol 2000 14 (Suppl. 1 318 319.
8. Chamlin SL, Kao J, Frieden IJ et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 2002 47 : 198 208.
9. Kolbe L, Kligman AM, Schreiner V et al. Corticosteroid-induced atrophy and barrier impairment measured by non-invasive methods in human skin. Skin Res Technol 2001 7 : 73 77.
10. Kao JS, Fluhr JW, Man MQ et al. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol 2003 120 : 456 464.
11. Berard F, Marty JP, Nicolas JF. Allergen penetration through the skin. Eur J Dermatol 2003 13 : 324 330.
12. Nicolas JF, Rozieres A, Castelain M. Pathogenesis of atopic dermatitis. Ann Dermatol Venereol 2005 1 : 1S44 1S52.
13. Ellis C, Luger T, Abeck D et al. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br J Dermatol 2003 148 (Suppl. 63 3 10.
14. Hanifin JM, Hebert AA, Mays SR et al. Effects of a low-potency corticosteroid lotion plus a moisturizing regimen in the treatment of atopic dermatitis. Curr Ther Res Clin Exp 1998 59 : 227 233.
15. Lucky AW, Leach AD, Laskarzewski P et al. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol 1997 14 : 321 324.
16. Kunz B, Oranje AP, Labreze L et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997 195 : 10 19.
17. Furue M, Terao H, Rikihisa W et al. Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. Br J Dermatol 2003 148 : 128 133.
18. Stoppoloni G, Prisco F, Santinelli R et al. Potential hazards of topical steroid therapy. Am J Dis Child 1983 137 : 1130 1131.
19. Ruiz-Maldonado R, Zapata G, Lourdes T et al. Cushing's syndrome after topical application of corticosteroids. Am J Dis Child 1982 136 : 274 275.
20. Curtis JA, Cormode E, Laski B et al. Endocrine complications of topical and intralesional corticosteroid therapy. Arch Dis Child 1982 57 : 204 207.
21. Consensus Conference Management of atopic dermatitis in children. Recommendations (short version). Eur J Dermatol 2005 15 : 215 223.
22. Ben-Gashir MA, Seed PT, Hay RJ. Quality of life and disease severity are correlated in children with atopic dermatitis. Br J Dermatol 2004 150 : 284 290.
23. Yasukawa K, Takido M, Matsumoto T et al. Sterol and triterpene derivatives from plants inhibit the effects of a tumor promoter, and sitosterol and betulinic acid inhibit tumor formation in mouse skin two-stages carcinogenesis. Oncology 1991 48 : 72 76.